(NASDAQ: SENS) Senseonics Holdings's forecast annual revenue growth rate of 65.41% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.71%, and it is also forecast to beat the US market's average forecast revenue growth rate of 23.07%.
Senseonics Holdings's revenue in 2026 is $29,298,000.On average, 10 Wall Street analysts forecast SENS's revenue for 2026 to be $2,497,432,509, with the lowest SENS revenue forecast at $2,202,270,994, and the highest SENS revenue forecast at $2,899,275,463. On average, 10 Wall Street analysts forecast SENS's revenue for 2027 to be $3,624,308,836, with the lowest SENS revenue forecast at $2,975,067,906, and the highest SENS revenue forecast at $4,422,111,126.
In 2028, SENS is forecast to generate $5,684,228,955 in revenue, with the lowest revenue forecast at $4,580,641,951 and the highest revenue forecast at $6,854,415,250.